Talkiatry will now have new resources on PPD. These include information on the symptoms, a web-based assessment, and the option to arrange a virtual consult with one of Talkiatry’s board-certified psychiatrists.
Biogen is also making these resources accessible through their Zurzuvae patient website (quinolone) to support women who have symptoms of PPD. This represents another trend where pharma companies use telehealth to increase awareness, support patients, and promote their products.
Talkiatry reported that one-eighth of US women experience PPD symptoms. These can include feelings of despair, anxiety, anger and guilt. However, getting the necessary care can be difficult, resulting in delayed diagnoses and treatments.
A shortage of psychiatrists can cause delays in initial consultations lasting months. Telehealth is an excellent way to bridge that gap. According to the specialist in telepsychiatry, most consultations are $30 or under for those with insurance.
The statistics are clear – many mothers are struggling with mental illness, yet they aren’t receiving timely diagnosis or treatment,” Georgia Gaveras, chief medical officer and co-founder of Talkiatry.
She added, “We aim to provide parents with support a safe, effective, and timely care pathway, assuring them that they will receive immediate, professional care by a psychiatrist licensed in the state.”
In August 2023, the FDA approved Zurzuvae for use as an oral treatment for postpartum depression. However, it rejected the product for its more prominent indication, major depressive disorders (MDD), reducing earlier sales expectations.
Biogen reported sales of $27,000,000 for Zurzuvae during the first six months of the year. Jefferies analysts have suggested that it can make $250 to $500 million per year with a PPD.
Talkiatry’s deal opens a network offering consultations in 43 US states, and over 60 insurance plans cover the service. Recently, the company raised $130m in a round of financing headed by Andreessen-Horowitz. The money will be used to expand its value-based model to treat behavioral health.
Read for more:https://medicalguro.com/icmrs-pioneering-study-highlights-how-these-foods-are-driving-the-diabetes-crisis-in-india/
